Companies / Latvia
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
Latvia's Reimbursement Budget Balloons
June 2006 | Market Trend AnalysisSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
Latvia's reimbursement budget for this year has been increased by 40% to EUR61mn (US$77mn), indicating that the country's drugs market is maturing quicker than expected. However, patients will be expected to pay for around of half of total pharmaceutical spending in